Characteristics and LDL-C Therapeutic Objectives of Patients Receiving Unusual Lipid-Modifying Therapy Regimens

Aug-10

AUTHORS : Dr Eric Van Ganse, Lyon Pharmaco-Epidemiology Unit- UMR 5558 CNRS-Claude Bernard Lyon 1 University, Lyon, France – Email: eric.van-ganse@univ-lyon1.fr – Cannot find details of other authors

JOURNAL : Pharmacoepidemiology and Drug Safety

REFERENCE: 19(S1):157

DOI : 10.1002/pds.2019

Characteristics and LDL-C Therapeutic Objectives of Patients Receiving Unusual Lipid-Modifying Therapy Regimens

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study